Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
474 - Dear PAAB. Can sales reps distribute disease information directly to patients?
-
This is not recommended for prescription drugs sales reps because it is generally not considered to be ethical and it likely contravenes regulatory provisions depending on the content and context of the interaction (patient information must be non-promotional). The company can send non-promotional disease information from their medical information department to patients who specifically request it. It is the accepted role of health care professionals to distribute health and treatment related information to patients. Also see Q&A 293 & 215.
